Zobrazeno 1 - 10
of 699
pro vyhledávání: '"Geretti E"'
Publikováno v:
Journal of Nanobiotechnology. 11/22/2024, Vol. 22 Issue 1, p1-24. 24p.
Publikováno v:
Proteins-Structure Function and Bioinformatics, 54, 4, pp. 768-75
Proteins-Structure Function and Bioinformatics, 54, 768-75
Proteins-Structure Function and Bioinformatics, 54, 768-75
Contains fulltext : 60567.pdf (Publisher’s version ) (Closed access) Binding of interleukin-8 (IL-8) to glycosaminoglycans (GAGs) on the surface of endothelial cells is crucial for the recruitment of neutrophils to an inflammatory site. Deriving st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f33780cda523d402ce8fddd02562ee3b
https://hdl.handle.net/2066/60567
https://hdl.handle.net/2066/60567
Autor:
Basirinia, Ghazal1,2 (AUTHOR) domenico.diraimondo@unipa.it, Ali, Muhammad1,2 (AUTHOR) amuhammad@fondazionerimed.com, Comelli, Albert2,3 (AUTHOR) acomelli@fondazionerimed.com, Sperandeo, Alessandro4 (AUTHOR) sperandeo@lamaddalenanet.it, Piana, Sebastiano4 (AUTHOR) piana.sebastiano@lamaddalenanet.it, Alongi, Pierpaolo5,6 (AUTHOR) pierpaolo.alongi@arnascivico.it, Longo, Costanza5 (AUTHOR) costanza.longo@arnascivico.it, Di Raimondo, Domenico1 (AUTHOR), Tuttolomondo, Antonino1 (AUTHOR), Benfante, Viviana1,6 (AUTHOR) acomelli@fondazionerimed.com
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 19, p3323. 22p.
Autor:
Medina Pérez, Víctor Manuel1 (AUTHOR) mbaselga@iisaragon.es, Baselga, Marta1 (AUTHOR), Schuhmacher, Alberto J.1,2 (AUTHOR) vmmedina@iisaragon.es
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 15, p2681. 35p.
Autor:
Dumont N; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Merrigan S; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Turpin J; McGill University, Goodman Cancer Center, Montreal, Quebec, Canada., Lavoie C; McGill University, Goodman Cancer Center, Montreal, Quebec, Canada., Papavasiliou V; McGill University, Goodman Cancer Center, Montreal, Quebec, Canada., Geretti E; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Espelin CW; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Luus L; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Kamoun WS; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Ghasemi O; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Sahagian GG; Tufts University, Sackler School of Graduate Biomedical Sciences, Boston, MA, USA., Muller WJ; McGill University, Goodman Cancer Center, Montreal, Quebec, Canada., Hendriks BS; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Wickham TJ; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA., Drummond DC; Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA. Electronic address: ddrummond@merrimack.com.
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2019 Apr; Vol. 17, pp. 71-81. Date of Electronic Publication: 2019 Jan 14.
Autor:
Geretti, E., Espelin, C., Adiwijaya, B., Dumont, N., Coma, S., Koncki, Z., Garcia, G., Bloom, T., Rimkunas, V., Reynolds, J., Campbell, K., Moyo, V., Molnar, I., Lorusso, P., Miller, K., Ma, C., Krop, I.E., Munster, P., Wickham, T.
Publikováno v:
In Annals of Oncology 1 October 2016 27 Supplement 6:vi539-vi539
Autor:
Munster P; Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California, San Francisco, CA, USA. Pmunster@medicine.ucsf.edu., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., LoRusso P; Yale Cancer Center, New Haven, CT, USA., Ma C; Department of Medicine and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Siegel BA; Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Shields AF; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Molnár I; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Wickham TJ; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Reynolds J; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Campbell K; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Hendriks BS; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Adiwijaya BS; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Geretti E; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Moyo V; Research and Development, Merrimack Pharmaceuticals, Inc, Cambridge, MA, USA., Miller KD; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2018 Oct; Vol. 119 (9), pp. 1086-1093. Date of Electronic Publication: 2018 Oct 26.
Autor:
Saito, Naoya1 (AUTHOR) naoya.saito@konicaminolta.com, Matsuo, Tsukasa1 (AUTHOR), Tsuda, Hitoshi2 (AUTHOR), Yokota, Hiroyuki1 (AUTHOR), Okada, Hisatake1 (AUTHOR)
Publikováno v:
PLoS ONE. 5/15/2024, Vol. 19 Issue 5, p1-14. 14p.
Autor:
Nasimi Shad, Arya1 (AUTHOR), Moghbeli, Meysam2 (AUTHOR) Meysam_moghbeli@yahoo.com
Publikováno v:
Cell Communication & Signaling. 5/13/2024, Vol. 22 Issue 1, p1-12. 12p.
Autor:
Lee H; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. hlee@merrimack.com., Shields AF; Karmanos Cancer Institute, Detroit, Michigan., Siegel BA; Siteman Cancer Center, Washington University, St. Louis, Missouri., Miller KD; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana., Krop I; Dana-Farber Cancer Institute, Boston, Massachusetts., Ma CX; Siteman Cancer Center, Washington University, St. Louis, Missouri., LoRusso PM; Yale Cancer Center, New Haven, Connecticut., Munster PN; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Campbell K; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Gaddy DF; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Leonard SC; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Geretti E; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Blocker SJ; Karmanos Cancer Institute, Detroit, Michigan., Kirpotin DB; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Moyo V; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Wickham TJ; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts., Hendriks BS; Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Aug 01; Vol. 23 (15), pp. 4190-4202. Date of Electronic Publication: 2017 Mar 15.